The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade.
 
Biagio Ricciuti
Honoraria - Targeted Oncology
Consulting or Advisory Role - Amgen; AstraZeneca; Guidepoint Inc; Regeneron
 
Eleonora Gariazzo
No Relationships to Disclose
 
Teresa Gorria
Honoraria - GlaxoSmithKline
Travel, Accommodations, Expenses - Brystol-Myers Squibb; Dr. Reddy's Laboratories; MSD; Pfizer
 
Rohit Thummalapalli
No Relationships to Disclose
 
Fabrizio Citarella
Honoraria - AstraZeneca; Novartis
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Lilly
 
Malini Marion Gandhi
No Relationships to Disclose
 
Arielle Elkrief
Honoraria - Astrazeneca; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - Bristol Myers Squibb
Other Relationship - Canadian Institutes of Health Research (CIHR); Cedars Cancer Center; Royal College of Surgeons and Physicians of Canada
 
Federica Pecci
No Relationships to Disclose
 
Joao Victor Machado Alessi
No Relationships to Disclose
 
Alessandro Di Federico
No Relationships to Disclose
 
Maisam Makarem
No Relationships to Disclose
 
Arushi Saini
No Relationships to Disclose
 
Mihaela Aldea
Consulting or Advisory Role - Viatris
Research Funding - Amgen (Inst); AstraZeneca (Inst)
Travel, Accommodations, Expenses - Sandoz
 
Javier Baena Espinar
Honoraria - AstraZeneca Spain; AstraZeneca Spain; Bristol-Myers Squibb/Pfizer
Consulting or Advisory Role - Access Oncology; AstraZeneca Spain; Roche; Roche
Expert Testimony - Roche
Travel, Accommodations, Expenses - Janssen Oncology; MSD; MSD; Roche; Roche
 
Alessio Cortellini
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; IQvia; MSD Oncology; OncoC4
Speakers' Bureau - AstraZeneca; Eisai
 
Adam Jacob Schoenfeld
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Enara Bio; Heat Biologics; Immunocore; Iovance Biotherapeutics; Johnson & Johnson/Janssen; KSQ Therapeutics; Legend Biotech; Lyell Immunopharma; Merck; Oppenheimer; Perceptive Advisors; Prelude Therapeutics; Umoja Biopharma
Research Funding - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
Travel, Accommodations, Expenses - Instil Bio; Iovance Biotherapeutics
Other Relationship - Achilles Therapeutics; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Harpoon therapeutics; Instil Bio; Iovance Biotherapeutics; Merck; PACT Pharma
 
Frank Aboubakar Nana
No Relationships to Disclose
 
Laura Mezquita
Consulting or Advisory Role - AstraZeneca Spain; Janssen; MSD Oncology; Roche; Takeda
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb Spain; Janssen Oncology; MSD Oncology; Pfizer; Roche; Takeda
Research Funding - Amgen; AstraZeneca Spain; Bristol-Myers Squibb; Gilead Sciences (Inst); Inivata
Travel, Accommodations, Expenses - AstraZeneca; BMS; Roche; Takeda
 
Giulio Metro
No Relationships to Disclose
 
Mark M. Awad
Consulting or Advisory Role - Affini-T Therapeutics; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Foundation Medicine; Gritstone Bio; Instil Bio; Janssen; Merck; Mirati Therapeutics; Novartis; Pfizer; Regeneron
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bristol Myers Squibb Foundation